Jeffrey M. Leiden, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 27,340 shares at $234.49 ($6.4M) on 2020-02-25, disclosed to the SEC on 2020-02-26.
Seasonal sale ($6.4M) by CEO & President — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $239.23 | 8,410 | $2.0M | 31.3% |
| 2 | $229.77 | 2,273 | $522K | 8.1% |
| 3 | $229.77 | 2,273 | $522K | 8.1% |
| 4 | $230.40 | 1,120 | $258K | 4.0% |
| 5 | $231.76 | 1,050 | $243K | 3.8% |
| 6 | $232.96 | 1,017 |
| $237K |
| 3.7% |
| 7 | $232.96 | 1,017 | $237K | 3.7% |
| 8 | $234.49 | 1,640 | $385K | 6.0% |
| 9 | $234.49 | 1,640 | $385K | 6.0% |
| 10 | $235.53 | 1,210 | $285K | 4.4% |
| 11 | $235.53 | 1,210 | $285K | 4.4% |
| 12 | $236.63 | 560 | $133K | 2.1% |
| 13 | $236.63 | 560 | $133K | 2.1% |
| 14 | $238.33 | 1,680 | $400K | 6.2% |
| 15 | $238.33 | 1,680 | $400K | 6.2% |
| Total | $235.43 avg | 27,340 | $6.4M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |